
Õþ²ßËٵݣº¹ú¼ÒÒ½±£¾ÖÒ»Á¬·¢ÎÄÍÆ¶¯DRGˢУ¬£¬£¬£¬£¬µÚËÄÅú¹ú¼Ò×éÖ¯¸ßÖµÒ½ÓúIJļ¯²É¿ª±ê
Ò½ÁÆÕþ²ß
-
¹ú¼ÒÒ½±£¾Ö»Ø¸´£ºÖ§³ÖÁ¢ÒìÒ½ÁÆÆ÷е£¬£¬£¬£¬£¬¿íÃâDRG
12ÔÂ15ÈÕ£¬£¬£¬£¬£¬¹ú¼ÒÒ½±£¾ÖÐû²¼ÁË¡¶¹ØÓÚÕþÐÊ®ËĽìÌìÏÂίԱ»áµÚÒ»´Î¾Û»áµÚ02870ºÅ£¨Éç»áÖÎÀíÀà217ºÅ£©Ìá°¸»Ø¸´µÄº¯¡·£¬£¬£¬£¬£¬Ã÷È·Ìá³ö¡°ÃãÀø½«ÐÂÊÖÒÕ¡¢ÐÂÒ©Æ·¡¢ÐÂÆ÷еÄÉÈë°ü¹Ü¹æÄ££¬£¬£¬£¬£¬Òý·¢Ò©Æ·ÆóÒµÁ¢ÒìÑз¢¶¯Á¦£»£»£»£»£»£»ÔÚDRG/DIPµÈÒ½±£Ö§¸¶·½·¨Ë¢ÐÂÖУ¬£¬£¬£¬£¬³ä·Ö˼Á¿ÐÂÊÖÒÕ¡¢ÐÂÒ©Æ·¡¢ÐÂÆ÷еµÄÓ¦Ó㬣¬£¬£¬£¬¿ÆÑ§²âË㲡ÖÖ·ÖÖµ£¬£¬£¬£¬£¬²¢½¨É趯̬µ÷½â»úÖÆ¡£¡£¡£¡£¡± »Ø¸´º¯Ç¿µ÷£¬£¬£¬£¬£¬DRG/DIPÖ§¸¶·½·¨Ë¢ÐµÄÄ¿µÄÊÇ¡°µ½2025Äêµ×ÁýÕÖËùÓÐÇкÏÌõ¼þµÄÒ½ÁÆ»ú¹¹¡±¡£¡£¡£¡£
½ñÄêÄêÍ·£¬£¬£¬£¬£¬¹ú¼ÒÒ½±£¾ÖµãÃûÖ§³ÖµØ·½Ò½±£²¿·ÖÔÚÊÔµãÊÂÇéÖн¨ÉèCHS-DRG¸¶·ÑÖ§³ÖÒ½ÁÆÐÂÊÖÒյĻúÖÆ¡£¡£¡£¡£7Ô£¬£¬£¬£¬£¬±±¾©×÷ΪÊԵ㶼»áÐû²¼ÁË¡¶¹ØÓÚÓ¡·¢CHS-DRG¸¶·ÑÐÂÒ©ÐÂÊÖÒÕ³ýÍâÖ§¸¶ÖÎÀí²½·¥µÄ֪ͨ¡·£¬£¬£¬£¬£¬Ã÷È·Ìá³ö¡°ÊÔÐв»°´DRG·½·¨Ö§¸¶Á¢ÒìÒ©¡¢Á¢ÒìÒ½ÁÆÆ÷е¡¢Á¢ÒìÒ½ÁÆÐ§ÀÍÏîÄ¿£¬£¬£¬£¬£¬¶øÊǽÓÄɵ¥¶À¾Ýʵ֧¸¶µÄ·½·¨¡±¡£¡£¡£¡£
Õþ²ßÆÊÎö£º
£¨1£©ÔÚ½ñÄê×ÊÔ´Êг¡ÕûÌ寣ÈíµÄÌåÏÖÏ£¬£¬£¬£¬£¬¹ú¼ÒÒ½±£¾Ö¶à´ÎÁÁÏàDRG/DIPË¢ÐÂÎȲ½Íƽø£¬£¬£¬£¬£¬¹ØÓÚ±£»£»£»£»£»£»¤º£ÄÚÒ½ÁÆÁ¢ÒìÆø·Õ¾ßÓÐÖ÷ÒªÒâÒ壬£¬£¬£¬£¬Îª¸ßÖµÁ¢ÒìÒ½ÁƲúÆ·Ò»Á¬ÌṩÊг¡¿Õ¼ä
-
¹ãÖÝÍ·²¿Èý¼×ҽԺͬÃ˼¯½ÓÄÉÈë¸ßÖµºÄ²ÄÐÂÃæÄ¿
12ÔÂ13ÈÕ£¬£¬£¬£¬£¬¹ã¶«Ê¡¹ãÖݹ«¹²×ÊÔ´ÉúÒâÖÐÐÄÐû²¼¡¶¹ãÖÝÒ½ÓúIJÄÒ½ÁÆ»ú¹¹ÁªºÏ²É¹ºÎļþ£¨¾µ¼¹ÜÈ˹¤×Ô¶¯Âö°êĤÖû»ÏµÍ³¡¢¿É³äµçÖ²ÈëʽÄÔÉµç´Ì¼¤¡¢ÑªÁ÷µ¼ÏòÃÜÍøÖ§¼Ü£©£¨Õ÷ÇóÒâ¼û¸å£©¡·¡£¡£¡£¡£±¾´Î²É¹ºÖ÷ÌåΪÖÐɽ´óѧÁ¥ÊôµÚÒ»Ò½Ôº¡¢¹ã¶«Ê¡ÈËÃñÒ½Ôº¡¢ÖÐɽ´óѧËïÒÝÏɼÍÄîÒ½Ôº¡¢ÖÐɽ´óѧÁ¥ÊôµÚÈýÒ½Ôº¡¢ÖÐɽ´óѧÁ¥ÊôµÚÁùÒ½Ôº¡¢ôßÄÏ´óѧÁ¥ÊôµÚÒ»Ò½Ôº¡¢¹ãÖÝÒ½¿Æ´óѧÁ¥ÊôµÚÒ»Ò½ÔºµÈ7¼ÒÒ½Ôº£¬£¬£¬£¬£¬ÁªºÏ²É¹ºÖÜÆÚΪ1Äê¡£¡£¡£¡£±¾´Î¼¯²ÉÈý´óÀàºÄ²ÄÖУ¬£¬£¬£¬£¬ÑªÁ÷µ¼ÏòÃÜÍøÖ§¼ÜÔÚºÓÄϺͱ±¾©µÄҽԺͬÃ˾ùÒÑ·ºÆð¹ý£¬£¬£¬£¬£¬¶øTAVI¡¢DBSÔòÊôÓÚ¼¯²ÉµÄÐÂÏÊÃæÄ¿£¬£¬£¬£¬£¬Ê״ηºÆð¡£¡£¡£¡£
Õþ²ßÆÊÎö£º
£¨1£©?ÏÖ½×¶ÎTAVI¡¢DBSµÈ¸ßÖµºÄ²ÄÈÔÈ»Ö÷ÒªÓÃÓÚº£ÄÚ¶¥¼âµÄÈý¼×Ò½Ôº£¬£¬£¬£¬£¬Êг¡ÉÐδ·¿ª¡£¡£¡£¡£½ñÄê6Ô£¬£¬£¬£¬£¬±±¾©´óÈý¼×ͬÃ˲ɹºÉñ¾½éÈëÀà¸ß²Åƽ¾ù½µ·ùΪ20%£¬£¬£¬£¬£¬×÷Ϊ²Î¿¼£¬£¬£¬£¬£¬±¾´Î¼¯²É¹ØÓÚTAVI¡¢DBS¹ú²ú³§ÉÌÒ²ÊÇË«Èн££¬£¬£¬£¬£¬¹ú²ú³§ÉÌÔõÑùÒÔ¼Û»»Á¿£¬£¬£¬£¬£¬ÕÆÎÕ½øÔºÊ±»ú£¬£¬£¬£¬£¬ÖµµÃÆÚ´ý¡£¡£¡£¡£
-
Õã½Ê¡Ò½±£¾Ö¾ÍDRG¼¤ÀøÕ÷ÇóÒâ¼û
12ÔÂ8ÈÕ£¬£¬£¬£¬£¬Õã½Ê¡Ò½±£¾ÖÐû²¼¡¶Õã½Ê¡Á¢ÒìÒ½Ò©ÊÖÒÕÒ½±£Ö§¸¶¼¤ÀøÖÎÀí²½·¥£¨ÊÔÐУ©£¨Õ÷ÇóÒâ¼û¸å£©¡·¡£¡£¡£¡£¹ØÓÚÖª×ãÒªÇóµÄÁ¢ÒìÆ÷еÌá¸ß¼¤Àø×ܶ£¬£¬£¬£¬¸÷ÉèÇøÊÐÒ½±£²¿·Ö¿É°´½ñÄê¶ÈDRGÕûÀí×ܶîµÄÒ»¶¨±ÈÀýÈ·¶¨¼¤Àø×ܶ£¬£¬£¬£¬²¢ÎȲ½¼Ó´ó¼¤ÀøÁ¦¶È¡£¡£¡£¡£¶Ô¹ú¼Ò¡¢Ê¡ÖصãʹÃüµÄ¶¨µãÒ½ÁÆ»ú¹¹µÄ¸ß¶ËÐÂÊÖÒÕºÍÖÐÒ½Ò©ÐÂÊÖÒÕ£¬£¬£¬£¬£¬Êʵ±ÑÓÉìÒ»ÄêÍËÆÂʱ¼ä¡¢Ìá¸ß¼¤ÀøÏµÊý¡£¡£¡£¡£
£¨1£©ÕûÌåÉÏÀ´¿´£¬£¬£¬£¬£¬´Ë´Î¼¤ÀøÖ÷ÒªÕë¶Ô¸ß¶ËÁ¢ÒìÒ½ÁÆÆ÷е£¬£¬£¬£¬£¬µ÷½âÁ¦¶È½ÏΪÎÂ˳
-
µÚËÄÅú¹ú¼Ò×éÖ¯¸ßÖµÒ½ÓúIJļ¯²É¿ª±ê
11ÔÂ30ÈÕ£¬£¬£¬£¬£¬µÚËÄÅú¹ú¼Ò×éÖ¯¸ßÖµÒ½ÓúIJļ¯²É¿ª±ê£¬£¬£¬£¬£¬´Ë´Î¼¯²ÉÁýÕֵĸßÖµÒ½ÓÃºÄ²ÄÆ·ÖÖÖ÷Òªº¸ÇÈ˹¤¾§ÌåÀࣨ11ÖÖ£©ºÍÔ˶¯Ò½Ñ§ÀàºÄ²Ä£¨20ÖÖ£©ºÏ¼Æ31¸ö¸ßÖµÒ½ÓúIJÄÏà¹ØÆ·ÖÖ£¬£¬£¬£¬£¬Éæ¼°¼ÓÈëÆóÒµÊýÄ¿128¼Ò£¬£¬£¬£¬£¬ÖÐÑ¡ÆóÒµÊýĿΪ126¼Ò£¬£¬£¬£¬£¬ÖÐÑ¡Âʵִï98%¡£¡£¡£¡£
½µ¼Û·ù¶È·½Ã棬£¬£¬£¬£¬È˹¤¾§ÌåÀàÀàºÄ²Äƽ¾ù½µ¼Û·ù¶ÈΪ60%¡¢Ô˶¯Ò½Ñ§ÀàºÄ²Äƽ¾ù½µ¼Û·ù¶ÈΪ74%£¬£¬£¬£¬£¬ËùÓиßÖµºÄ²ÄÕûÌå½µ¼Û·ù¶ÈԼΪ70%¡£¡£¡£¡£¼¯²ÉµÄÆ·ÖÖÑ¡ÔñÁË»¼Õß»ùÊý´ó¡¢ÐèÇóÊýÄ¿¶àµÄÈ˹¤¾§ÌåÀàºÄ²Ä£¬£¬£¬£¬£¬ÒÔ¼°×÷Ϊ´ËǰÈ˹¤ÊàŦºÍ¼¹ÖùÀàºÄ²Ä½øÒ»²½Ôö²¹Ð͵ÄÔ˶¯Ò½Ñ§ÀàºÄ²Ä¡£¡£¡£¡£
£¨1£©ÆóÒµÖÐÑ¡Âʽϸߣ¬£¬£¬£¬£¬¸ßÖµºÄ²Ä½µ¼Û·ù¶ÈÇ÷ÓÚÎÂ˳£¬£¬£¬£¬£¬±£»£»£»£»£»£»¤Á¢ÒìÐͲúÆ·ÀûÈó¿Õ¼ä£¬£¬£¬£¬£¬ÊµÏÖ¹ú²úÌæ»»
£¨2£©È˹¤¾§ÌåÀàºÍÔ˶¯Ò½Ñ§ÀàºÄ²Ä¼¯²ÉµÄÀֳɿª±ê£¬£¬£¬£¬£¬½«½øÒ»²½Êͷż¯²ÉˢеÄÖÆ¶ÈÐÔÓ¯Àû£¬£¬£¬£¬£¬¼õÇáȺÖڼ縺
-
²ÆÎñ²¿ÖúÁ¦Î÷ÄÏÎ÷±±µØÇøÖÝÀïÎÀÉúÔº²É¹ºÒ½ÁÆ×°±¸
11ÔÂ3ÈÕ²ÆÎñ²¿Ðû²¼¡¶Í¨Öª¡·ÖúÁ¦Î÷ÄÏÎ÷±±µØÇøÖÝÀïÎÀÉúÔº²É¹ºÒ½ÁÆ×°±¸£¬£¬£¬£¬£¬Ö÷ÒªÓÃÓÚÖ§³ÖÎ÷²¿µØÇø¾àÀëÏØ³Ç½ÏÔ¶¡¢Ð§ÀÍÉú³Ý½Ï¶à¡¢ÕïÁÆÌõ¼þÓдýÌáÉýµÄÖÝÀïÎÀÉúÔºÉèÖÃÉý¼¶Ò½ÁÆ×°±¸£¬£¬£¬£¬£¬ÌáÉý»ù±¾ÕïÁÆÄÜÁ¦¡£¡£¡£¡£¸ÃÏî×ʽð½òÌù½«ÓÃÓÚÎ÷ÄÏÎ÷±±µØÇøÎªÖ÷µÄ13µØµÄ228¼ÒÖÝÀïÎÀÉúÔº£¬£¬£¬£¬£¬Æ½¾ùÿ¼Ò½«»ñµÃ200ÍòµÄ½òÌù×ʽ𡣡£¡£¡£
£¨1£©ÓÐÍû·¿ªº£ÄÚϲãÊг¡£¡£¡£¡£¬£¬£¬£¬£¬ÊµÏÖÒ½ÁÆ×ÊԴϳÁµ½ÖÝÀïÎÀÉúÔº£º×÷ΪϲãÒ½ÁÆÐ§ÀÍϵͳµÄÊàŦ£¬£¬£¬£¬£¬ÖÝÀïÎÀÉúÔºÆðµ½ÁË¡°³ÐÉÏÆôÏ¡±µÄÖ÷Òª×÷Ó㬣¬£¬£¬£¬Ëæ×Źú¼Ò¡°Ç¿Ï²㡱Õþ²ßµÄÒ»Ö±Â䵨£¬£¬£¬£¬£¬ÌìÏÂ3.6Íò¼ÒÖÝÀïÎÀÉúÔºÆñÂÛÊÇÕïÁÆÐ§ÀÍÄÜÁ¦ÕÕ¾ÉÒ½ÁÆ×°±¸´¢±¸Ò²½«»ñµÃÖÜÈ«ÌáÉý¡£¡£¡£¡£
£¨2£©ÓÐÍû·¿ªº£ÄÚϲãÊг¡£¡£¡£¡£¬£¬£¬£¬£¬ÊµÏÖÒ½ÁÆ×ÊԴϳÁµ½ÖÝÀïÎÀÉúÔº£º×÷ΪϲãÒ½ÁÆÐ§ÀÍϵͳµÄÊàŦ£¬£¬£¬£¬£¬ÖÝÀïÎÀÉúÔºÆðµ½ÁË¡°³ÐÉÏÆôÏ¡±µÄÖ÷Òª×÷Ó㬣¬£¬£¬£¬Ëæ×Źú¼Ò¡°Ç¿Ï²㡱Õþ²ßµÄÒ»Ö±Â䵨£¬£¬£¬£¬£¬ÌìÏÂ3.6Íò¼ÒÖÝÀïÎÀÉúÔºÆñÂÛÊÇÕïÁÆÐ§ÀÍÄÜÁ¦ÕÕ¾ÉÒ½ÁÆ×°±¸´¢±¸Ò²½«»ñµÃÖÜÈ«ÌáÉý¡£¡£¡£¡£
×ʽðÕÙļÇéÐÎ
- ÆÕÂå˹×îÐÂÒ»ÆÚÖйúÊÕÒæ»ù½ðÍê³ÉÕÙ£¬£¬£¬£¬Í¶×ʹæÄ£54ÒÚÔª
11ÔÂ25ÈÕ£¬£¬£¬£¬£¬ÆÕÂå˹GLP×îÐÂÒ»ÆÚÖйúÊÕÒæ»ù½ðÍê³ÉÕÙ£¬£¬£¬£¬Í¶×ʹæÄ£´ï54ÒÚÔª¡£¡£¡£¡£¸Ã»ù½ðͶ×ÊÈËΪº£ÄÚÁìÏȵİü¹Ü»ú¹¹£¬£¬£¬£¬£¬ÆÕÂå˹µ£µ±»ù½ðÖÎÀíÈËÒÔ¼°×ʲúÖÎÀíÈË¡£¡£¡£¡£¸Ã»ù½ðÊÇÆÕÂå˹±¾¼¾¶ÈÔÚÖйúÍê³ÉÕÙļµÄµÚ¶þÖ§ÊÕÒæÐÍ»ù½ð£¬£¬£¬£¬£¬Í¶×ÊÓÚÉϺ£¡¢Çൺ¡¢Î人¡¢³¤É³µÈÎïÁ÷½¹µãÊàŦµÄ13´¦ÎȹÌÔËÓªµÄÏÖ´ú»¯ÎïÁ÷»ù´¡ÉèÊ©¡£¡£¡£¡£Ô°ÇøÖ÷ҪЧÀÍÓÚÆû³µ¼°ÁãÅä¼þ¡¢»úÐµÖÆÔì¡¢µç×ÓµçÆ÷¡¢Ò½Ò©¼°Ò½ÁÆ×°±¸µÈ¸ß¶ËÖÇÄÜÖÆÔìÒµ£¬£¬£¬£¬£¬ÉÐÓÐÐÂÖÊÁÏ¡¢¹¤Òµ»úеÈË¡¢°ëµ¼ÌåµÈÐÂÐ˹¤Òµ£¬£¬£¬£¬£¬º¸ÇÖйú¾¼ÃÉý¼¶×ªÐ͵ÄÖ÷ÒªÁìÓò¡£¡£¡£¡£
- Ê×ÆÚ¹æÄ£51ÒÚÔª£¬£¬£¬£¬£¬³¤Èý½ÇרÏî»ù½ðÕýʽ½¨Éè
11ÔÂ23ÈÕ£¬£¬£¬£¬£¬ÌìÏÂÉç±£»£»£»£»£»£»ù½ð³¤Èý½Ç¿Æ¼¼Á¢Òì¹ÉȨͶ×Ê»ù½ðÔÚÉϺ£¾ÙÐнÒÅÆÒÇʽ£¬£¬£¬£¬£¬Ê×ÆÚ¹æÄ£51ÒÚÔª£¬£¬£¬£¬£¬IDG×ÊÔ´µ£µ±»ù½ðÖÎÀíÈË¡£¡£¡£¡£»£»£»£»£»£»ù½ð½«Á¬Ïµ¹ú¼Ò¹¤ÒµÉú³¤Õþ²ßºÍ³¤Èý½ÇµØÇøÕ½ÂÔÉú³¤Æ«Ïò£¬£¬£¬£¬£¬ÖصãÎ§ÈÆ¼¯³Éµç·¡¢ÉúÎïÒ½Ò©¡¢È˹¤ÖÇÄÜ¡¢µç×ÓÐÅÏ¢¡¢ÉúÃü¿µ½¡¡¢ÐÂÄÜÔ´Æû³µ¡¢¸ß¶Ë×°±¸¡¢ÏȽøÖÊÁÏ¡¢ÎïÁªÍø¡¢´óÊý¾Ý¡¢ÖÇÄÜÖÆÔìµÈÖØµãÁìÓò¿ªÕ¹Í¶×ʽṹ£¬£¬£¬£¬£¬¼ÓËÙ¹¹½¨ÏÖ´ú»¯¹¤ÒµÏµÍ³¡£¡£¡£¡£
-
Çຣʡĸ»ù½ðÍê³É±¸°¸£¬£¬£¬£¬£¬×ܹæÄ£50ÒÚÔª
11ÔÂ22ÈÕ£¬£¬£¬£¬£¬ÇຣÊ׸öÕþ¸®Í¶×Êĸ»ù½ð¡ª¡ªÇຣʡ¸ßÖÊÁ¿Éú³¤Õþ¸®Í¶×Ê»ù½ð£¨¼ò³Æ¡°Çຣʡĸ»ù½ð¡±£©ÔÚÖйú֤ȯͶ×Ê»ù½ðҵлáÍê³É±¸°¸¡£¡£¡£¡£»£»£»£»£»£»ù½ðÓÉÇຣ½ð²ÆË½Ä¼Í¶×Ê»ù½ðÖÎÀíÓÐÏÞ¹«Ë¾µ£µ±ÖÎÀíÈË£¬£¬£¬£¬£¬ÈϽɹæÄ£50ÒÚÔª£¬£¬£¬£¬£¬ÆäÖÐÊ×ÆÚ³ö×Ê15ÒÚÔªÒÑʵ½Éµ½Î»£¬£¬£¬£¬£¬²¢¶¨Î»Îª×¤×ãÇàº£ÌØÓÐ×ÊÔ´Ù÷¸³£¬£¬£¬£¬£¬¾Û½¹¹¤Òµ¡°Ëĵء±¿ªÕ¹Í¶×Ê£¬£¬£¬£¬£¬Í¬Ê±Ö§³ÖÖÐСÆóÒµ¼°Á¢Òì´´ÒµÉú³¤£¬£¬£¬£¬£¬°üÀ¨ÌØÉ«ÐÂÖÊÁÏ¡¢×°±¸ÖÆÔìÉý¼¶¡¢¸ßÔÉúÎïºÍ¿µÑø¹¤Òµ¼°Êý×Ö¹¤Òµ»¯µÈ£¬£¬£¬£¬£¬¶ÔÖ§³Ö¡°Ëĵء±½¨ÉèµÄ×Ó»ù½ðͶ×Ê×ܶî¶È²»µÍÓÚ70%¡£¡£¡£¡£
- Ԫϣº£ºÓ»ù½ðÍê³É±¸°¸£¬£¬£¬£¬£¬¹æÄ£5ÒÚÔª
11ÔÂ8ÈÕÐÂÎÅ£¬£¬£¬£¬£¬ÔªÏ£º£ºÓÉúÎïÒ½Ò©¹¤Òµ»ù½ðÕýʽÐû²¼Íê³ÉÖлùб¸°¸£¬£¬£¬£¬£¬×ܹæÄ£5ÒÚÔªÈËÃñ±Ò¡£¡£¡£¡£»£»£»£»£»£»ù½ðΪ½ðɳ½ÁªºÏ×ÊÔ´¼Ì¡°Èóè±Ò½ÁÆ»ù½ð¡±ºóÐû²¼µÄµÚ¶þ֧רעÓÚͶ×ÊÉúÃü¿ÆÑ§ºÍÒ½ÁÆ¿µ½¡ÐÐÒµµÄÒ½ÁÆ»ù½ð£¬£¬£¬£¬£¬×¨×¢ÓÚͶ×ÊÉúÃü¿ÆÑ§ºÍÒ½ÁÆ¿µ½¡ÐÐÒµ£¬£¬£¬£¬£¬ÖصãͶ×ÊÁìÓò°üÀ¨Á¢ÒìÒ©¡¢ÉúÎïÊÖÒÕ¼°Ïà¹Ø¹¤ÒµÁ´¡£¡£¡£¡£±¾´ÎÕÙļԪϣº£ºÓ»ù½ð»ñµÃ¶à¼ÒÕþ¸®Ö¸µ¼»ù½ðºÍÒ½Áƹ¤Òµ·½µÄ¶¦Á¦´ó¾ÙÖ§³Ö£¬£¬£¬£¬£¬ÆäÖаüÀ¨¿µÏ£ÅµÉúÎï¹É·Ý¹«Ë¾¡¢Ìì½òÊк£ºÓ¹¤Òµ»ù½ðµÈ¡£¡£¡£¡£
?ÐÂҩתÈûØÊ×
±í1£º11ÔÂÐÂÒ©License in / License outÏîĿһÀÀ

Ò»¼¶Êг¡º£ÄÚÍâÒ½ÁÆÁìÓòÈÚ×Ê
3.1. º£ÄÚÒ½ÁÆÈÚ×Ê£ºÖØµã¹Ø×¢Á¢ÒìÒ©Îï¡¢½á¹¹ÐÔÐÄÔಡÀàÆ÷е
2023Äê11Ô£¬£¬£¬£¬£¬º£ÄÚÒ»¼¶Êг¡Í¶×Ê102¼ÒÒ½ÁÆÆóÒµ¡£¡£¡£¡£±¾Ô£¬£¬£¬£¬£¬ÉúÎïҽҩͶ×ÊÏîÄ¿¶à¼¯ÖÐÓÚÁ¢ÒìÒ©ÎïÑз¢Æ«Ïò£»£»£»£»£»£»Ò½ÁÆÆ÷е·½Ã棬£¬£¬£¬£¬¶à¼ÒѪ¹Ü½éÈëÀàÆ÷е¹«Ë¾Åû¶ÈÚ×Ê¡£¡£¡£¡£
ͼ1£º2023Äê11Ôº£ÄÚÒ½ÁÆ¿µ½¡ÁìÓòͶ×ÊÖ÷ÒªÂþÑÜÔÚÉúÎïÒ½Ò©¡¢Ò½ÁÆÆ÷е£º
±í2£º11Ôº£ÄÚÉúÎïÒ½Ò©¼°ÉÏÓÎÁìÓòÈÚ×ÊÏîĿһÀÀ
±í3£º11Ôº£ÄÚÒ½ÁÆÆ÷еÁìÓòÈÚ×ÊÏîĿһÀÀ
±í5£º11Ôº£ÄÚÒ½ÁÆÐ§ÀÍÁìÓòÈÚ×ÊÏîĿһÀÀ
±í6£º11Ôº£ÄÚÊý×ÖÒ½ÁÆºÍÆäËûÁìÓòÈÚ×ÊÏîĿһÀÀ
3.2 ÍâÑóÒ½ÁÆÈÚ×Ê£ºÖØµã¹Ø×¢ÉúÎïÊÖÒÕÁìÓò
±¾Ô£¬£¬£¬£¬£¬ÍâÑóÒ½ÁÆÈÚ×ÊÈȰñÖ®Ê×À´×Ô²¢¹º£¬£¬£¬£¬£¬Ä¬É³¶«Ðû²¼ÒÔ6.1ÒÚÃÀÔªÊÕ¹ºÉúÎïÊÖÒÕ¹«Ë¾Caraway Therapeutics¡£¡£¡£¡£×ݹ۱¾ÔÂͶÈÚ×ÊÊÂÎñ£¬£¬£¬£¬£¬ÉúÎïÊÖÒÕÊÇÍâÑóͶ×Ê»ú¹¹ÖØµã¹Ø×¢Æ«Ïò¡£¡£¡£¡£ÆäÖÐUniversal DX£¨UDX£©»ñµÃÀ´×ÔQuest DiagnosticsµÄ7000ÍòÃÀÔªBÂÖ×¢×Ê¡£¡£¡£¡£UDXÖÂÁ¦ÓÚͨ¹ýÔçÆÚ¼ì²â½«°©Ö¢×ª±äΪ¿ÉÖÎÓúµÄ¼²²¡£¡£¡£¡£¬£¬£¬£¬£¬ÏÖÔÚ£¬£¬£¬£¬£¬UDXÖ÷ҪרעÓÚ½áÖ±³¦°©µÄ¼ì²â£¬£¬£¬£¬£¬µ«ÆäÊÖÒÕÇ徲̨Ҳ¿ÉÒÔÓÃÓÚʶ±ðÓëÆäËû¸ß¼ç¸º°©Ö¢Ïà¹ØµÄÆæÒìDNAÐòÁÐÇøÓò¡£¡£¡£¡£×¨×¢ÓÚ¿ª·¢ÐÂÐÍС·Ö×ÓÒ©ÎïµÄÉúÎïÊÖÒÕ¹«Ë¾Gate BioscienceÐû²¼»ñµÃÀ´×ÔVersant VenturesºÍGoogle VenturesÁìͶµÄ6000ÍòÃÀÔªAÂÖ×¢×Ê¡£¡£¡£¡£Gate BioscienceµÄ·Ö×ÓÃſط¢Ã÷ƽ̨£¨Molecular Gate Discovery Platform£©¿ÉÒÔ¸ßͨÁ¿É¸Ñ¡Ð¡·Ö×ÓÎĿ⣬£¬£¬£¬£¬²¢¶ÔÕû¸öÉøÍ¸ÂѰ××é¾ÙÐÐÖÜÈ«¡¢¶¨Á¿µÄÆÊÎö£¬£¬£¬£¬£¬ÒÔ¿ª·¢Ñ¡ÔñÐÔÁÆ·¨¡£¡£¡£¡£ÕâÏîÊÖÒÕÓÐDZÁ¦¸Ä±äÏÖÔÚ¶ÔÖ÷Òª¼²²¡µÄÖÎÁÆ·½·¨£¬£¬£¬£¬£¬Îª»¼Õß´øÀ´Ï£Íû¡£¡£¡£¡£2023Äê11ÔÂ22ÈÕ£¬£¬£¬£¬£¬ÉúÎ﹤³ÌÊÖÒÕ¹«Ë¾VivodyneÐû²¼Íê³ÉÁË×ܶî3800ÍòÃÀÔªµÄÖÖ×ÓÂÖÈÚ×Ê¡£¡£¡£¡£Õâ±Ê×ʽðÓÉKhosla VenturesÁìͶ£¬£¬£¬£¬£¬Kairos Ventures¡¢CS Ventures¡¢MBX CapitalºÍBison Ventures¼ÓÈëͶ×Ê¡£¡£¡£¡£Vivodyneͨ¹ýÉúÎ﹤³ÌÖÆÔìÁË20¶àÖÖ²î±ðÀàÐ͵ÄÈËÌåÆ÷¹Ù×éÖ¯£¬£¬£¬£¬£¬ÕâЩ×éÖ¯Äܹ»Ä£ÄâÈËÌåµÄÐÄÀíºÍ¹¦Ð§¡£¡£¡£¡£¹«Ë¾µÄƽ̨Äܹ»×÷ÓýºÍÆÊÎöÁè¼Ý10,000¸öµ¥¶ÀµÄÈËÀà×éÖ¯£¬£¬£¬£¬£¬Ê¹ÓûúеÈË×Ô¶¯»¯ÊÖÒÕ¾ÙÐвÙ×÷¡£¡£¡£¡£ÕâÑù¿ÉÒÔ±¬·¢´ó×ÚµÄÈËÀàÊý¾Ý¼¯£¬£¬£¬£¬£¬Ö§³ÖÏÂÒ»´úÒÔÈËΪѵÁ·µÄÈ˹¤ÖÇÄÜÒ©Îï·¢Ã÷¡£¡£¡£¡£
±í7£º11ÔÂÍâÑóÒ½ÁÆ¿µ½¡×ÅÃû»ú¹¹Í¶×ÊÏîĿһÀÀ
IPOºÍ²¢¹º
4.1 IPO£ºÒ½Áƹ«Òæ×éÖ¯DocolaÌá½»ÉÏÊÐÉêÇ룬£¬£¬£¬£¬Ò©Ã÷ºÏÁª¸Û¹ÉÉÏÊÐ
11Ô£¬£¬£¬£¬£¬ÄÉ˹´ï¿Ë3¼Ò¹«Ë¾É걨IPO£¬£¬£¬£¬£¬ÃÀ½»Ëù1¼Ò¹«Ë¾É걨£¬£¬£¬£¬£¬Ïã¸ÛÖ÷°å1¼Ò¹«Ë¾É걨¡£¡£¡£¡£ÃÀ¹É·½Ã棬£¬£¬£¬£¬ÁÙ´²½×¶ÎÖÆÒ©¹«Ë¾Sequoia Vaccines¡¢Ï¸°ûÁÆ·¨¹«Ë¾FibroBiologics¡¢ÐÂÐÍС·Ö×ÓÑз¢¹«Ë¾Telomir Pharmaceuticals¡¢ÓëÒ½Áƹ«Òæ×éÖ¯DocolaÌá½»ÉÏÊÐÉêÇë¡£¡£¡£¡£º£ÄÚÉÏÊз½Ã棬£¬£¬£¬£¬±¾ÔÂÉÏÊÐ1¼ÒÆóÒµÒ©Ã÷ºÏÁª¡£¡£¡£¡£ÍâÑóÉÏÊз½Ã棬£¬£¬£¬£¬ÃÀ¹úÉúÒâËùÉÏÊÐ2¼ÒÉúÎï¿Æ¼¼ÆóÒµ£¬£¬£¬£¬£¬Mural OncologyÓëCARGO Therapeutics¡£¡£¡£¡£
±í8£º11ÔÂA¹É¡¢¸Û¹É¡¢ÃÀ¹ÉIPOÉ걨һÀÀ
±í9£º11ÔÂA¹É¡¢¸Û¹É¡¢ÃÀ¹ÉÉÏÊÐÒ»ÀÀ
4.2 ²¢¹º£ºÖÇ·ÉÉúÎïÊÕ¹ºå·°²ÉúÎï100%¹ÉȨ£¬£¬£¬£¬£¬½á¹¹Î÷Ò©ÁìÓò
±í10£º11ÔÂA¹É¡¢¸Û¹É²¢¹ºÒ»ÀÀ
ÃâÔðÉùÃ÷
Ïà¹ØÄÚÈÝ»ùÓÚÒѹûÕæµÄ×ÊÁÏ»òÐÅϢ׫д£¬£¬£¬£¬£¬µ«±¾¹«Ë¾²»°ü¹Ü¸ÃµÈÐÅÏ¢¼°×ÊÁϵÄÍêÕûÐÔ¡¢×¼È·ÐÔ£¬£¬£¬£¬£¬Ëùº¬ÐÅÏ¢¼°×ÊÁϼá³ÖÔÚ×îÐÂ״̬¡£¡£¡£¡£Í¬Ê±£¬£¬£¬£¬£¬±¾¹«Ë¾ÓÐȨ¶Ô±¾±¨¸æËùº¬ÐÅÏ¢ÔÚ²»·¢³ö֪ͨµÄÇéÐÎÏÂ×ö³öÐ޸쬣¬£¬£¬£¬ÔĶÁÕßÓ¦µ±×ÔÐйØ×¢ÏìÓ¦µÄ¸üлòÐ޸ġ£¡£¡£¡£ÔÚÈκÎÇéÐÎÏ£¬£¬£¬£¬£¬±¾ÆªÎÄÕÂÖеÄÐÅÏ¢»òËù±íÊöµÄÒâ¼û¾ù²»×é³É¶ÔÈκÎÈ˵ÄͶ×ʽ¨Ò飬£¬£¬£¬£¬ÎÞÂÛÊÇ·ñÒѾÕÑʾ»òÌåÏÖ£¬£¬£¬£¬£¬±¾±¨¸æ²»¿É×÷ΪµÀÒåµÄ¡¢ÔðÈεĺÍÖ´·¨µÄÒÀ¾Ý»òÕ߯¾Ö¤¡£¡£¡£¡£ÔÚÈκÎÇéÐÎÏ£¬£¬£¬£¬£¬±¾¹«Ë¾Òà²î³ØÈκÎÈËÒòʹÓñ¾ÎÄÕÂÖеÄÈκÎÄÚÈÝËùÒýÖµÄÈκÎËðʧ¸ºÈκÎÔðÈΡ£¡£¡£¡£±¾ÎÄÕ½öΪ±¾¹«Ë¾ËùÓУ¬£¬£¬£¬£¬Î´¾ÊÂÏÈÊéÃæÔÊÐí£¬£¬£¬£¬£¬Èκλú¹¹ºÍСÎÒ˽¼Ò²»µÃÒÔÈκÎÐÎʽ·°æ¡¢¸´ÖÆ¡¢½ÒÏþ¡¢×ª·¢»òÒýÓñ¾±¨¸æµÄÈκβ¿·Ö¡£¡£¡£¡£